Hyperfine, Inc. (HYPR) vs Pulmonx Corporation (LUNG)
Hyperfine, Inc. and Pulmonx Corporation are both Medical Devices companies. Hyperfine, Inc. and Pulmonx Corporation are of similar size ($84.4M and $81.6M). Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against −3.43%. Pulmonx Corporation has the higher net margin (−55.0% vs −210.8%) and the higher return on invested capital (−141.0% vs −401.8%). Across the 18 metrics below, Pulmonx Corporation leads on 11 and Hyperfine, Inc. on 7.
Valuation
Profitability
| Metric | HYPR | LUNG | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.41% | 77.06% | 56.01% |
| Operating margin | (203.27%) | (52.96%) | (15.03%) |
| Net margin | (210.75%) | (55.03%) | (20.40%) |
| Free cash flow margin | (166.48%) | (35.07%) | (7.24%) |
| Return on equity | (96.97%) | (88.87%) | (15.32%) |
| Return on assets | (64.40%) | (36.74%) | (19.72%) |
| Return on invested capital | (401.79%) | (141.03%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack